Perth Biotech Pioneer Receives International Award

 

Resonance Health is delighted to announce that Chief Scientific Officer Professor Tim St Pierre has received a significant award from the Thalassemia International Federation (TIF), in recognition of the contribution made by FerriScan, the MRI-based measurement for liver iron concentration (LIC), to the lives of patients worldwide.

TIF is dedicated to improving access to high quality medical care for sufferers of this group of genetic diseases, and to work towards its eventual eradication. The Panos Englezos Prize, named in honour of the long-serving President of TIF, is awarded jointly by The University of Nicosia Medical School and TIF on a biannual basis and was presented at a ceremony at the University today.

In awarding Professor St Pierre with the prestigious Panos Englezos Prize, TIF has acknowledged the impact of FerriScan in improving the lives and clinical outcomes of patients worldwide since its introduction in 2005. 

FerriScan was developed at the University of Western Australia by Professor St Pierre and his team. The MRI-based image analysis service is provided by Resonance Health, based in Claremont, Western Australia. Today, more than 30,000 FerriScans have been delivered to patients in over 30 countries worldwide.

This achievement was noted by Dr Englezos “We are indeed very proud to acknowledge the tremendous contribution that the 30,000 FerriScans have had to the global patients’ community. There is no doubt that the contribution of the FerriScan programme had great value and identified the many needs of patients across the globe.”

Thalassaemia is a haemoglobinopathy, a group of genetic diseases that impact the production and functionality of a patient’s haemoglobin. Treatment often involves regular blood transfusions, resulting in an excess of iron, which may accumulate in the liver, causing liver fibrosis, cancer and death. In some cases excessive iron absorption occurs even in the absence of blood transfusions.

The ability to accurately measure the amount of iron in the liver enables doctors to better determine a patient’s treatment regime, significantly improving their chances of disease-free survival.

Professor St Pierre said; “I am thrilled to have been honoured with the Panos Englezos Award from TIF and the University of Nicosia Medical School.  A major part of my working life has been aimed at improving monitoring techniques for thalassaemia patients with a view both to furthering knowledge about this condition and advancing its management. TIF is a highly recognised body that has supported patients and families and thalassaemia research around the world.  As such, I consider this award a very great honour and a huge incentive to keep pushing ahead to make further progress.”

The prize consists of a silver drop of blood (TIF’s logo) and a monetary award of USD $10,000 which will be used to further access to FerriScan in economically disadvantaged regions

For further information contact:

Sander Bangma, General Manager, Resonance Health

Phone: +61 (8) 9286 5300

Email: sanderb@resonancehealth.com web: www.resonancehealth.com